Read posts about government

February 21

More on "Lessig for Congress" (Martin Gordon's Blog (cptncelchu)) by Martin

Ars Technica has a great article today on Professor Lessig's potential run for Congress that I mentioned yesterday. The article does an excellent job of outlining Lessig's platform in far better detail than the one sentence I gave it. What's particularly interesting about his position is his desire to build a Creative Commons in Congress, where "[i]f politicians begin foreswearing PAC money, the theory runs, voters may come to see the failure to refuse lobbyist dollars as a badge of shame rather than simply the way things are done." This sounds like a very necessary change and requires the proverbial "Washington outsider" to really get going - Lessig is that outsider. Further, the article elaborates on the difference between Lessig and his greatest rival in the race, Jackie Speier. Lessig mentions that there aren't many differences, but that a focus on technology would give him an edge and that even though many prominent California Democrats have thrown their support behind Speier, the rush to consolidate support has frustrated voters who want more options. As I said yesterday, I can't wait to see how this plays out.

Technorati Tags: , , , , , , , ,

Posted in: books , copyright , free , government , information , internet , politics
February 20

Lessig May Run For Congress (Martin Gordon's Blog (cptncelchu)) by Martin

I wrote about Professor Larry Lessig's shift in focus from Free Culture to corruption in Washington when he gave his last Free Culture talk. Since then, a seat has opened up in Congress as a result of the death of California Congressman Tom Lantos. Lessig posted on his weblog earlier today that a Facebook group and the draftlessig08.org website have caused him to actually consider running.

I think Lessig has a great chance of winning thanks to support from the tech community. Having him in Congress would not only be excellent for his next project, but would also help along causes that current Congress members are either too tech illiterate or too influenced by money to really address the right way (one such cause being Net Neutrality).

There's no word on when he'll make a decision, but along with the rest of the tech community, I wait with bated breath.

Technorati Tags: , , , , , ,

Posted in: books , copyright , free , government , information , internet , politics
August 30

Now you Europeans can waste your money on aliskiren, too (OnThePharm (Hanser)) by RJS

Novartis has gotten their pointless direct renin inhibitor approved by the European equivalent of the FDA.

How utterly snooze-worthy. Now you Europeans can waste your tax dollars money on the drug, too! Hooray!

Bonus Tekturna story:

Doctor writes a prescription for Tekturna for one of his patients. (One of our drug delivery guys, actually.) Gives him a free sample card, even though he doesn’t have insurance and thinks he’s doing him a favor. He gets 30 Tekturna for free, and the next month rolls around. That’ll be $100, please, even with the employee discount I gave him because he amuses me.

He almost shit a brick.

Remember, folks: giving patients a FREE SAMPLE is great, but it’s a complete WASTE OF EVERYONE’S TIME if they are without insurance or if their insurance doesn’t cover it.

Mr. Delivery Guy comes back a week later with a prescription for lisinopril, after I write him a note to give to his bonehead physician.

Sometimes I wonder…

Technorati Tags: , ,

Posted in: government , therapeutic pipeline
August 24

Big career changes: talking to the .gov (Kilala.nl (Cailin Coilleach)) by Cailin Coilleach

About an hour ago I had my final meeting from the long list of appointments I'd made in light of my career change. After talking to teachers, schools, students, my employer and so on I finally got to talk to the government. The CWI (Centrum voor Werk en Inkomen / Center for Work and Income) is the part of the government that jobless people go to talk to. They are the ones who cover finance of those missing out on (a part of) a job.

Finding the place turned out to be harder than the talk itself. I had a quick chat with a friendly lady who was rather amused by my case. The only way I could get an appointment at the CWI was to register a new account with them, faking that I was going to be unemployed ^_^ After we got things going it soon became clear that I'd already covered all my options and had explored all avenues.

So, while the talk itself didn't give me any new insights, it did provide me with something important: reassurance that I'm on the right track.

Posted in: career change , career switch , centrum voor werk en inkomen , cwi , government

Big career changes: talking to the .gov (Kilala.nl (Cailin Coilleach)) by Cailin Coilleach

About an hour ago I had my final meeting from the long list of appointments I'd made in light of my career change. After talking to teachers, schools, students, my employer and so on I finally got to talk to the government. The CWI (Centrum voor Werk en Inkomen / Center for Work and Income) is the part of the government that jobless people go to talk to. They are the ones who cover finance of those missing out on (a part of) a job.

Finding the place turned out to be harder than the talk itself. I had a quick chat with a friendly lady who was rather amused by my case. The only way I could get an appointment at the CWI was to register a new account with them, faking that I was going to be unemployed ^_^ After we got things going it soon became clear that I'd already covered all my options and had explored all avenues.

So, while the talk itself didn't give me any new insights, it did provide me with something important: reassurance that I'm on the right track.

Posted in: career change , career switch , centrum voor werk en inkomen , cwi , government
April 1

Zelnorm yanked. But it might come back? (OnThePharm (Hanser)) by RJS

Zelnorm (tegaserod) has been yanked — not a big surprise in our litigation-happy society. I can understand the CYA-above-all-else policy, but in this case, though, I think patient education and discussion would be a far superior option than removing a novel drug from the shelves entirely. I’ve seen first-hand several instances where Zelnorm worked when nothing else did. (Lubiprostone just came out, remember.)

But in a recent analysis of 18 000 patients in the entire clinical database, adverse cardiovascular events were seen in 13 out of 11 614 patients (0.11%) on Zelnorm, but in only one patient (0.01%) out of 7031 taking placebo, a statistically significant difference.

I happen to know that these people are willing to deal with this risk to continue to lead healthier lives. When a drug is yanked, it’s a no-win situation, especially when it’s one-of-a-kind like this. The kicker is whether there’s even any meaningful risk at all:

Quoted in a company press release as “an independent cardiologist,” Dr Jeffrey L Anderson (University of Utah, Salt Lake City) commented, “My review of the data suggested that a causal relationship is unlikely between tegaserod and the rare cardiovascular ischemic events observed in clinical trials. Furthermore, the data did not show any consistent pattern of event type, time to event, or dose relationship in tegaserod-treated patients.”

The FDA is willing to consider letting Zelnorm back into the wild again. I hope they do.

Here’s to hoping Amitiza (lubiprostone) can fill Zelnorm’s shoes as effectively in the meantime. But knowing drugs like this, it’ll probably work for some, but not for others, leaving some left out in the cold. Again.

Technorati Tags: , ,

Posted in: fda , government , litigation , medical practice , money
January 20

Mandatory HPV vaccination in Maryland (OnThePharm (Hanser)) by RJS

Nearly half of Maryland’s state senate has signed onto a bill requiring that all middle school girls receive Gardasil.

“Having the ability to eliminate a disease is something that cannot and should not be overlooked and should be made available to young girls,” said Sen. Gwendolyn T. Britt (D-Prince George’s), one of 21 senators who have signed onto the bill, sponsored by state Sen. Dolores G. Kelley (D-Baltimore County.)

[…]

Several Maryland lawmakers said the vaccine would affect their families directly. “I have two teenage daughters,” said Sen. Brian E. Frosh (D-Montgomery), a co-sponsor. “I don’t want them to get cancer.”

Not to get too political or anything, but it always strikes me as faintly amusing that disease states don’t discriminate between the social classes. Do we need to start sending the children of US Senators to war before that particular idiocy is stopped?

Anyways, on a related note, I got a script for Gardasil at the pharmacy yesterday (first time) that wasn’t covered by her insurance. Naturally, we don’t stock it normally, but the cost to her would have been $180 per round or $540 in total. Naturally she didn’t take it, but it does get me wondering where I could have told her to go to get it for less. She was more interested in her own knee-jerk “No way you’re crazy!” reaction than taking a more productive approach, however. But for the future, does anyone have any ideas?

Technorati Tags: , , ,

Posted in: culture , government
January 10

Requiring Gardasil in Washington D.C. (OnThePharm (Hanser)) by RJS

While South Dakota is focusing on girls ages 11-18, Washington D.C. is focusing on girls age 13 and under. Female students enrolling in the sixth grade would be required to show proof that they’ve received the vaccination. It is possible for parents to opt-out out of the vaccine, but the circumstances this would be permitted under haven’t been detailed.

I’m going to go ahead and speculate that these conditions involve “constitutional rights” — that is someone could have a religious aversion to vaccines, so their children would be permitted to opt-out. (A phenomenon that still makes me scratch my head.) No other “valid” reasons for opting out spring readily to mind.

Catania’s decision to introduce the vaccine proposal was based in part on the high incidence of cervical cancer in the District. HPV causes cancer in about 10,000 women in the country annually and kills about 3,700, according to the American Cancer Society. The national incidence rate of the disease is 8.8 per 100,000 females, and the District’s rate is 13.5 per 100,000, according to the society.

Solid reasoning, I suppose. I wonder why DC has a higher incidence of cervical cancer? Any guesses?

Technorati Tags: , , ,

Posted in: culture , government , medical practice
September 4

Generic clopidogrel: whiplash for the masses (OnThePharm (Hanser)) by RJS

Saturday morning, we received a voicemail sent to all of the branches in our chain about the stopped production of generic clopidogrel. You may recall that Apotex shipped all of the generic it had on hand as soon as their deal with S-A and BMS fell through. Well a judge has just ordered Apotex to stop producing and shipping the generic, so you can see why Apotex was in a hurry to get everything they had out the door, just in case.

Fortunately, there’s not going to be a recall, so Judge Stein certainly made the right decision in that case, but I’m waiting to hear what the shakeout ends up being. Will generic clopidogrel remain on the market or will it disappear? The voicemail made it sound like our company’s supplies of the generic will hold for as long as it takes to resolve the matter once and for all, but that could just as well have been in response to Apotex assurances that everything would go swimmingly. The possibility that Apotex might lose wasn’t even considered, which I found disingenuous. That’s in stark contrast to this WaPo article which makes it sound as though Apotex has no chance of winning at all. (Which very well could mean that it was written from a press release from Sanofi-Aventis, given that there’s no stock response information for BMS listed, who also has a huge stake in Plavix’s fate.)

Frankly, I don’t know what to think. I’m not a lawyer, and I’m not familar with the patent dispute in this particular case. The folks at Patent Baristas don’t have much more, either. If the generic disappears, it’s going to piss a lot of people off, both patients and providers. Myself included. No one likes being jerked around, particularly when it affects their wallet.

Technorati Tags: , , , ,

Posted in: drug pricing , government , intellectual property , money

Plan B: You know you did something right when you’ve pissed everyone off (OnThePharm (Hanser)) by RJS

I’m a firm believer that one of the most important aspects of democracy is not a given outcome of a political debate, but is instead the constant push and pull of the ideas behind a decision. The decision to make Plan B available without a prescription was a long time in coming, and I support it fully.

I think it’s somewhat sad that it’s been overly politicized, but I guess that’s the price of doing something controversial in a country where the “religious right” has a lot more clout than is warranted. Politicians on both sides think the FDA has gone too far or hasn’t gone far enough. I’d say that the agency has done a good job with their Plan B policy so far, if for no other reason than the fact that no one’s completely happy with it.

Some of the nonsense on both sides is actually pretty funny, particularly when viewed with an eye towards history — especially the stuff from the right:

Coburn and other social conservatives said that the high doses of hormones in the pills carry risks, and that making them more easily available will encourage sexual activity and result in more unwanted pregnancies and sexually transmitted diseases.

That, my friends, is Grade A political BS. Opponents of oral contraception said the same stuff about “The Pill” when it first came out. It was then, and still is, a complete load of crap.

First of all, Plan B will prevent unwanted pregnancies. That’s why it exists, and it does its job quite well. That whole STD thing… is anyone else having 1960s flashbacks here? Hello, these arguments were made when the pill first came out. They were unsubstantiated then, how is today any different?

“This is a bad decision for women, for girls, for parents and for public health,” said Wendy Wright of Concerned Women for America, which led a campaign to block the decision. “The FDA’s decision today will only make things worse for American women.”

I’d love to hear the logic behind that one, backed up with some numbers. But wait, that’ll never happen because the numbers won’t be there, and the only thing the right will be able to come up with will be anecdotes here and there. And I’d put some serious money on that.

What does concern me is the current administration’s emphasis on teaching abstinence. I think a rigorous sexual education program would go a long way in preventing STD transmission — but that, of course, is a bad idea because it will encourage teenagers to have sex. (Insert a humongous roll-eyes emoticon here.) Nevermind that the US has the highest rates of teen pregnancy and STD transmission of any first world country. Clearly the abstinence emphasis isn’t working.

But the left isn’t entirely reasonable either.

Plan B’s backers, meanwhile, criticized the agency for not allowing the drug to be sold to everyone.

“We urge the FDA to revisit placing age restrictions on the sale of Plan B,” said Sens. Hillary Rodham Clinton (D-N.Y.) and Patty Murray (D-Wash.). But because the decision represents “real progress” and an “important step in restoring the American people’s faith in the FDA,” the senators said, they were lifting a hold they had imposed on von Eschenbach’s confirmation as FDA commissioner.

I don’t think it’s a good idea for it to be sold willy-nilly to anyone that wants it. Ideally it’d be only sold to the person who is going to use it so its use can be more closely monitored, and the procedure for using it — and how it works — can be made clear to the woman who needs it.

So we’ve got Plan B available OTC. Now it’d be nice if the lay public got on the “Plan B is not abortion” bandwagon. Because it’s not.

Technorati Tags: , , , , ,

Posted in: culture , fda , government